Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,503 | 33,510 | 37,873 | 40,710 | 1,005 |
| Marketable Securities | 1,331 | 1,552 | 1,916 | 4,364 | 8,357 |
| Receivables | 133 | 152 | 125 | 139 | 125 |
| TOTAL | $28,386 | $35,796 | $40,767 | $45,837 | $10,009 |
| Non-Current Assets | |||||
| PPE Net | 1,212 | 1,079 | 794 | 800 | 883 |
| Other Non-Current Assets | 75 | 75 | 75 | 75 | 70 |
| TOTAL | $1,287 | $1,154 | $869 | $875 | $953 |
| Total Assets | $29,673 | $36,950 | $41,636 | $46,712 | $10,962 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,390 | 1,437 | 500 | 717 | 577 |
| Accrued Expenses | 4,117 | 4,770 | 3,058 | 2,836 | 3,158 |
| TOTAL | $5,507 | $6,207 | $3,558 | $3,553 | $3,735 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 218 | 269 | 0 | 0 | 1,000 |
| TOTAL | $1,218 | $1,269 | $1,000 | $1,000 | $1,000 |
| Total Liabilities | $6,725 | $7,476 | $4,558 | $4,553 | $4,735 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,540 | 1,540 | 1,539 | 1,539 | 318 |
| Common Shares | 137,769 | 307 | 137,325 | 137,700 | 99,998 |
| Retained earnings | -114,771 | -107,926 | -100,226 | -95,540 | -93,765 |
| Other shareholders' equity | -50 | -38 | -21 | -1 | -6 |
| TOTAL | $22,948 | $29,474 | $37,078 | $42,159 | $6,227 |
| Total Liabilities And Equity | $29,673 | $36,950 | $41,636 | $46,712 | $10,962 |